April 26, 2021 by Maulik Bhagat
AArete, COVID Vaccines, Maulik Bhagat
April 26, 2021, Opinion

At present writing, all everyone is talking about is whether they’ve gotten their shot or when they’re getting their shot, and where they got it, what kind of shot they’re getting or what kind they would prefer. They are posting on social media about the difficulty of getting an appointment soon enough, close enough to
November 11, 2020 by Chain Drug Review
AArete, Leslie Lotano-Saba, Paul Vosters
Business, Leading Headlines, Pharmacy

CHICAGO — AArete, a global data and technology-centered consulting firm, which recently earned Crain’s Chicago Business 2020 Best Places to Work award, has officially welcomed Leslie Lotano-Saba as vice president, Pharmacy Solutions and Paul Vosters, as managing director. Leslie Lotano-Saba, vice president, Pharmacy Solutions, brings more than 35 years of pharmacy experience, primarily in government programs with healthcare
August 10, 2020 by Leslie Lotano-Saba and Duane Harrington
AArete, Duane, Leslie Lotano-Saba
August 10, 2020, Opinion

For several decades, low-income patients, providers and pharmacies alike have been realizing the cost-saving benefits of the 340B drug-pricing program. The program helps a range of health care providers (covered entities) such as disproportionate share hospitals, rural hospitals, children’s hospitals, FQHCs and other providers that serve vulnerable communities, by lowering the cost of outpatient prescription
July 30, 2020 by Duane Harrington and Leslie Lotano-Saba
AArete, COVID-19, Duane Harrington, Leslie Lotano-Saba
July 27, 2020, Opinion

Among the many promising advances in medical legislation over the past several decades has been the passage of “provider status” laws for pharmacists in many states. While the specifics vary from state to state, the general intent behind this legislation is to give patients increased access to some of the oft-underutilized services that pharmacists can
August 21, 2018 by Maulik Bhagat and Michael Kim
AArete, Maulik Bhagat, Michael Kim
Issue 08-13-2018, Opinion

NEW YORK — Thanks to the ever-growing applications of data analytics technology, chain drug stores have a unique opportunity to create benefits ranging from improved member outcomes to lowered spending. While the situation is evolving and the trail to driving better member health and reducing costs is still being blazed, chain pharmacies are recognizing the
May 3, 2018 by Maulik Bhagat and Michael Kim
AArete, Maulik Bhagat, Michael Kim
Opinion

Abuse of prescription opioid drugs is a significant contributor to the opioid epidemic that has struck across the United States. Prescription misuse plays a major role in the 115 daily overdose deaths and the overall economic burden of $78.5 billion per year. Addressing this issue is vital from both policy and analysis standpoints. That’s especially
February 26, 2018 by Natalie Kish, Maulik Bhagat and Chain Drug Review
AArete, CVS-Aetna, Maulik Bhagat, Natalie Kish
2018, Issue 02-26-2018, Issues, Leading Headlines, Opinion

CVS Health’s announcement that it would acquire Aetna for $69 billion is only one of recent health care services deals — which totaled $72 billion in 2016 and $76 billion after the third quarter of 2017, prior to CVS announcing the final deal. Across the industry, companies are increasingly leveraging these strategic partnerships to improve
September 5, 2017 by Maulik Bhagat, Michael Kim and Chain Drug Review
AArete, accountable care organizations, health care delivery, health care industry value chain, Maulik Bhagat, Michael Kim, retail pharmacies
Opinion

While there are many similarities between retail pharmacies and other retail businesses, two key factors provide a unique opportunity to improve operations and financial efficiency, in turn enabling better patient outcomes. The ability to develop close relationships with other players in the health care industry value chain, and the opportunity to utilize relevant data in